ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 160 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,480,706 | +485.3% | 132,561 | +2615.3% | 0.04% | +311.1% |
| Q3 2022 | $253,000 | -14.5% | 4,882 | -21.9% | 0.01% | -30.8% |
| Q2 2022 | $296,000 | -15.4% | 6,252 | -21.4% | 0.01% | -56.7% |
| Q2 2021 | $350,000 | +16.7% | 7,958 | +11.7% | 0.03% | -6.2% |
| Q4 2020 | $300,000 | -58.1% | 7,124 | -54.4% | 0.03% | -30.4% |
| Q3 2020 | $716,000 | +82.2% | 15,638 | +99.6% | 0.05% | +70.4% |
| Q2 2020 | $393,000 | +21.7% | 7,836 | +104.9% | 0.03% | -6.9% |
| Q2 2019 | $323,000 | -77.5% | 3,824 | -74.5% | 0.03% | -71.6% |
| Q1 2019 | $1,433,000 | +134.9% | 15,004 | +184.9% | 0.10% | +142.9% |
| Q2 2018 | $610,000 | +20.6% | 5,266 | -38.9% | 0.04% | -25.0% |
| Q4 2017 | $506,000 | – | 8,620 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |